Roivant Sciences Ltd. — Director's Dealing 2024

Dec 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2024-12-23

Reporting Person: Sukhatme Mayukh (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-23	Common Shares	M	10796	$3.85	Acquired	18847343	Direct
2024-12-23	Common Shares	S	10796	$12	Disposed	18836547	Direct
2024-12-24	Common Shares	M	185946	$3.85	Acquired	19022493	Direct
2024-12-24	Common Shares	S	185946	$12	Disposed	18836547	Direct
2024-12-26	Common Shares	M	689495	$3.85	Acquired	19526042	Direct
2024-12-26	Common Shares	S	689495	$12.01	Disposed	18836547	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-23	Stock Option (Right to Buy)	$3.85	M	10796	Disposed	2032-04-19	Common Stock (10796)	Direct
2024-12-24	Stock Option (Right to Buy)	$3.85	M	185946	Disposed	2032-04-19	Common Stock (185946)	Direct
2024-12-26	Stock Option (Right to Buy)	$3.85	M	689495	Disposed	2032-04-19	Common Stock (689495)	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.

F2: Award of stock options to purchase Common Shares with a vesting commencement date of April 20, 2022. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 equal monthly installments thereafter, subject generally to the reporting person's continuous service through each vesting date (unless otherwise provided in the applicable award documentation).